DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Cardiac fibrosis inhibitor CTPR390 prevents structural and morphological changes in human engineered cardiac connective tissue
Cardiac fibrosis is a key characteristic of heart failure. CTPR390, an experimental anti-fibrotic inhibitor targeting Hsp90, has shown success in animal models, but remains unexplored in human cardiac models. This study evaluated an engineered cardiac connective tissue (ECCT) model, focusing on changes in the extracellular matrix and fibroblasts. Results showed that CTPR390 prevented architectural changes in TGFβ1-activated ECCT, preserving tissue perimeter, collagen fibers alignment while reducing structured areas and degree of collagen structuration. CTPR390 treatment reduced cell area of fibroblasts under tension, without changes in the internal rounded cells devoid of tension. Fibroblast recruitment to tension areas was diminished, showing biomechanical behavior similar to control ECCT. This treatment also lowered the gene and protein expression of key pro-fibrotic markers. Here, advanced biotechnology was employed to detect the detailed structure of tissue fibrosis reduction after administering CTPR390, representing a significant advancement toward clinical application for cardiac fibrosis treatment., This work was partially supported by Agencia Estatal de Investigación (AEI/MCI/10.13039/501100011033), Spain. A.V.V. PID2021-125702OB-I00. Fomento de la transferencia de conocimiento en la Comunidad Autónoma de Cantabria SUBVTC-2023-0006 T. A.L.C. acknowledges support by the Agencia Estatal de Investigación Grant PDC2021-120957-I00-NanoIVD and PDC2022-133345-I00-ProIMAGE funded by MCIN/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR” and Grant PID2022-137977OB-I00-ProTher funded by MCIN/AEI/ 10.13039/501100011033. C.S.C. thanks Gipuzkoa Foru Aldundia (Gipuzkoa Fellows program) Grant number 2019-FELL-000018-01/62/2019 for financial support. G.G. thanks the financial support of “la Caixa” Foundation (ID100010434, fellowship: LCF/BQ/DI20/11780020). This work was performed under the Maria de Maeztu Units of Excellence and Severo Ochoa Centers Programs from the Spanish State Research Agency – Grants No. MDM-2017-0720 (CIC biomaGUNE) and CEX2018-000867-S (DIPC). O.M.C. and V.M. thank the AEI for the infrastructure EQC 2019-006589-P and the PREVAL 21/07 grant from IDIVAL., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2018-000867-S)., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-125702OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PDC2021-120957-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PDC2022-133345-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-137977OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 CEX2018-000867-S